29 related articles for article (PubMed ID: 10623812)
1. Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model.
Raes G; Van Ginderachter J; Liu YQ; Brys L; Thielemans K; De Baetselier P; Geldhof A
Cancer Immunol Immunother; 1998 Jan; 45(5):257-65. PubMed ID: 9439649
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.
Foss DL; Zilliox MJ; Murtaugh MP
Infect Immun; 1999 Oct; 67(10):5275-81. PubMed ID: 10496906
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma.
Wu RS; Kobie JJ; Besselsen DG; Fong TC; Mack VD; McEarchern JA; Akporiaye ET
Cancer Immunol Immunother; 2001 Jul; 50(5):229-40. PubMed ID: 11499806
[TBL] [Abstract][Full Text] [Related]
4. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression.
Baker-LePain JC; Sarzotti M; Fields TA; Li CY; Nicchitta CV
J Exp Med; 2002 Dec; 196(11):1447-59. PubMed ID: 12461080
[TBL] [Abstract][Full Text] [Related]
5. Gamma-ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells.
Morel A; Fernandez N; de La Coste A; Haddada H; Viguier M; Polla BS; Antoine B; Kahn A
Cancer Immunol Immunother; 1998 Jul; 46(5):277-82. PubMed ID: 9690456
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.
Puliaeva I; Soloviova K; Puliaiev M; Lang T; Puliaev R; Via CS
J Immunol; 2011 Jan; 186(1):291-304. PubMed ID: 21115734
[TBL] [Abstract][Full Text] [Related]
7. Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.
Li G; Wu X; Zhang F; Li X; Sun B; Yu Y; Yin A; Deng L; Yin J; Wang X
J Cancer Res Clin Oncol; 2011 Apr; 137(4):695-703. PubMed ID: 20563597
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions.
Neves AR; Ensina LF; Anselmo LB; Leite KR; Buzaid AC; Câmara-Lopes LH; Barbuto JA
Cancer Immunol Immunother; 2005 Jan; 54(1):61-6. PubMed ID: 15693140
[TBL] [Abstract][Full Text] [Related]
9. In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma.
Chen XL; Cao XD; Kang AJ; Wang KM; Su BS; Wang YL
World J Gastroenterol; 2003 Jun; 9(6):1370-3. PubMed ID: 12800259
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice.
Gorczynski RM; Chen Z; Hu J; Kai Y; Lei J
Clin Exp Immunol; 2001 Nov; 126(2):220-9. PubMed ID: 11703364
[TBL] [Abstract][Full Text] [Related]
11. Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity.
Dredge K; Marriott JB; Todryk SM; Muller GW; Chen R; Stirling DI; Dalgleish AG
J Immunol; 2002 May; 168(10):4914-9. PubMed ID: 11994441
[TBL] [Abstract][Full Text] [Related]
12. Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.
Moro M; Gasparri AM; Pagano S; Bellone M; Tornaghi P; Veglia F; Corti A; Casorati G; Dellabona P
Cancer Res; 1999 Jun; 59(11):2650-6. PubMed ID: 10363988
[TBL] [Abstract][Full Text] [Related]
13. Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models.
Jonker M; Ossevoort And MA; Vierboom M
Transplantation; 2002 Jan; 73(1 Suppl):S23-6. PubMed ID: 11810057
[TBL] [Abstract][Full Text] [Related]
14. Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model.
De Giovanni C; Nicoletti G; Landuzzi L; Palladini A; Lollini PL; Nanni P
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783695
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.
Martín-Fontecha A; Moro M; Crosti MC; Veglia F; Casorati G; Dellabona P
J Immunol; 2000 Jan; 164(2):698-704. PubMed ID: 10623812
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
